News

For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.

For patients dealing with cancer, a daily dose of inspiration may make a big difference in their outlook on life.

Patients who have human papillomavirus 16 DNA in their saliva following treatment of their oropharyngeal cancer are more likely to have their cancer recur, and a simple mouth rinse can be used to detect it.

Meta-analysis of 148 studies confirms benefit of spirituality and religion.

Rates of endometrial cancer continue to increase among all racial and ethnic groups, but they're rising faster among non-Hispanic black women who also have poorer outcomes when compared with their white, non-Hispanic counterparts.

Patients with Hodgkin lymphoma at risk of relapse or progression have a new treatment option following the FDA's expansion of the approved use of brentuximab vedotin (Adcetris).

Researchers at Oregon Health & Science University found that breast cancer survivors who experience pain during sexual intercourse may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

Lung cancer at any age is a catastrophic illness, but it is particularly devastating when it affects young adults in the prime of their lives.

A donation from Bristol-Myers Squibb Company to The Leukemia & Lymphoma Society (LLS) will provide financial assistance for chronic myeloid leukemia (CML) patients who need help paying for Polymerase Chain Reaction (PCR) testing.

Study finds long-term survival is not unusual.

Results from the phase III TELESTAR trial showed that oral telotristat etiprate proved much better than placebo in reducing carcinoid syndrome–related diarrhea.

Less than 50% of patients with ovarian cancer who could benefit from intraperitoneal chemotherapy actually receive it, despite research suggesting that this technique could improve survival for these patients.

Guidelines for metastatic breast cancer developed.

Oral contraceptives may provide long-term protection against endometrial cancer.

A study by the Cancer Support Community examined the factors that are most influential when patients choose a particular treatment option.

Though immunotherapies can provide significant survival benefit for patients with lung cancer, using the agents in practice is still unchartered territory for many clinicians.

Physicians appear to be the drivers of hospice care.

A diagnosis of breast cancer is difficult at any age but for younger women, treatment decisions can be especially difficult, with implications that include their future childbearing, sexual health, and body image.

Two web-based interventions that help men with prostate cancer deal with sexual dysfunction and other common side effects of treatment are demonstrating how tech tools can be successfully deployed to address the psychosocial needs of patients, their caregivers, and survivors.

For oncology clinicians and practices who want to meet new standards for more patient-centered cancer care, they need to do a better job of engaging patients more fully in their care planning and make patient-reported outcomes an integral part of cancer treatment research.

The patient-powered research registry ABOUT aims to increase knowledge about the best prevention, diagnostic, and treatment approaches for those affected directly or indirectly by hereditary cancer risk.

Although it is important for clinicians and their patients who are receiving anticancer treatment to discuss patients' fertility preservation options, a new study has found that whether these conversations take place and, importantly, whether ensuing action is taken, depends on a number of factors.

A new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, suggesting targeted intervention strategies may help to improve outcomes for this population of women.

Discussion is an integral component of the cancer treatment plan.

A new study is raising questions about the benefits of chemotherapy for patients with end-stage cancer, finding that in terms of quality of life, for many patients it does more harm than good.

A group of 118 well-known cancer experts have come together to spotlight the escalating costs of cancer treatment with an aim to galvanize patients and grassroots advocates to make their voices heard.

A phase III trial evaluating the efficacy of nivolumab (Opdivo) for the treatment of advanced renal cell carcinoma has been stopped early after the immunotherapy agent demonstrated a survival advantage over the comparator drug, everolimus (Afinitor), in the CheckMate-025 trial.

Women living in certain areas of the United States may face health risks due to their limited access to specialized gynecologic cancer care.

Laurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.

ASCO task force develops a framework to guide discussions.